BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 20690795)

  • 1. Restoration of fragile histidine triad (FHIT) expression inhibits cell growth and induces apoptosis in cutaneous T-cell lymphoma cell line.
    Song X; Tian Z; Wang S; Peng Z; Feng J
    Cancer Invest; 2010 Dec; 28(10):1019-23. PubMed ID: 20690795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ectogenous fragile histidine triad gene inhibits the malignant phenotype of human lung cancer cell line A549 in vitro and in vivo].
    Zhang LQ; Wang H; Lai BT; Yue WT; Zhan XP; Yang XH; Zhang CY; Zhang TM
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 May; 28(5):333-6. PubMed ID: 15949315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of ectogenous FHIT gene on reversing malignant phenotype of human lung adenocarcinoma cells A549].
    Wang Y; Zhuo Q; Qin Y; Yuan S; Sun Z; Wang Y; Chen X; Sun Z; Song Y; Yang Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Jun; 19(3):225-9. PubMed ID: 12048684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of fragile histidine triad gene on biologic properties of muco-epidermoid carcinoma cells.
    Liu F; Wu JZ; Li F; Li Y; Li J
    Cytotherapy; 2008; 10(7):753-8. PubMed ID: 18985481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of apoptosis and inhibition of tumorigenicity and tumor growth by adenovirus vector-mediated fragile histidine triad (FHIT) gene overexpression.
    Ji L; Fang B; Yen N; Fong K; Minna JD; Roth JA
    Cancer Res; 1999 Jul; 59(14):3333-9. PubMed ID: 10416589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-dependent effect of FHIT-inducible expression in Calu-1 lung cancer cell line.
    Cavazzoni A; Petronini PG; Galetti M; Roz L; Andriani F; Carbognani P; Rusca M; Fumarola C; Alfieri R; Sozzi G
    Oncogene; 2004 Nov; 23(52):8439-46. PubMed ID: 15361849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of the FHIT gene favors bladder cancer development.
    Vecchione A; Sevignani C; Giarnieri E; Zanesi N; Ishii H; Cesari R; Fong LY; Gomella LG; Croce CM; Baffa R
    Clin Cancer Res; 2004 Nov; 10(22):7607-12. PubMed ID: 15569992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential susceptibility of renal carcinoma cell lines to tumor suppression by exogenous Fhit expression.
    Werner NS; Siprashvili Z; Fong LY; Marquitan G; Schröder JK; Bardenheuer W; Seeber S; Huebner K; Schütte J; Opalka B
    Cancer Res; 2000 Jun; 60(11):2780-5. PubMed ID: 10850413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular genetic alterations of FHIT and p53 genes in benign and malignant thyroid gland lesions.
    Pavelić K; Dedivitis RA; Kapitanović S; Cacev T; Guirado CR; Danić D; Radosević S; Brkić K; Pegan B; Krizanac S; Kusić Z; Spaventi S; Bura M
    Mutat Res; 2006 Jul; 599(1-2):45-57. PubMed ID: 16698048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of fragile histidine triad gene transduction on proliferation and apoptosis of human hepatocellular carcinoma cells.
    Xu RH; Zheng LY; He DL; Tong J; Zheng LP; Zheng WP; Meng J; Xia LP; Wang CJ; Yi JL
    World J Gastroenterol; 2008 Jun; 14(23):3754-8. PubMed ID: 18595145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Impact of fragile histidine triad gene transfection on the proliferation and apoptosis of human colorectal cancer cell].
    Cao J; Liang LY; Yang P; Qian YJ; Wang H; Sun Z; Li WL; Tan MH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2010 Sep; 13(9):691-4. PubMed ID: 20878579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fhit regulates invasion of lung tumor cells.
    Joannes A; Bonnomet A; Bindels S; Polette M; Gilles C; Burlet H; Cutrona J; Zahm JM; Birembaut P; Nawrocki-Raby B
    Oncogene; 2010 Feb; 29(8):1203-13. PubMed ID: 19935706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of adenoviral transduction of the fragile histidine triad gene into esophageal cancer cells.
    Ishii H; Dumon KR; Vecchione A; Trapasso F; Mimori K; Alder H; Mori M; Sozzi G; Baffa R; Huebner K; Croce CM
    Cancer Res; 2001 Feb; 61(4):1578-84. PubMed ID: 11245468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of FHIT allelic imbalance/loss of heterozygosity and FHIT expression in cutaneous squamous cell carcinomas.
    Gray SE; Kay E; Leader M; Mabruk M
    J Cutan Pathol; 2008 Sep; 35(9):816-25. PubMed ID: 18494825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fhit protein inhibits cell growth by attenuating the signaling mediated by nuclear factor-kappaB in colon cancer cell lines.
    Nakagawa Y; Akao Y
    Exp Cell Res; 2006 Aug; 312(13):2433-42. PubMed ID: 16733051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the fragile histidine triad gene in normal rat tissues and human kidney cancer cell lines.
    Lee SH; Kim TJ; Kim HY; Kim JG; Park MK; Woo KM; Kim SH; Hwang KY; Nam HS; Min YK; Cho MH
    Res Commun Mol Pathol Pharmacol; 2002; 112(1-4):145-57. PubMed ID: 15080505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of FRA16D/WWOX and FRA3B/FHIT genes in hematopoietic malignancies.
    Ishii H; Vecchione A; Furukawa Y; Sutheesophon K; Han SY; Druck T; Kuroki T; Trapasso F; Nishimura M; Saito Y; Ozawa K; Croce CM; Huebner K; Furukawa Y
    Mol Cancer Res; 2003 Nov; 1(13):940-7. PubMed ID: 14638866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fragile histidine triad gene and skin cancer.
    Zanesi N; Croce CM
    Eur J Dermatol; 2001; 11(5):401-4. PubMed ID: 11525944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRAIL-induced apoptosis of FHIT-negative lung cancer cells is inhibited by FHIT re-expression.
    Mirandola P; Gobbi G; Sponzilli I; Malinverno C; Cavazzoni A; Alfieri R; Petronini PG; Vitale M
    J Cell Physiol; 2009 Aug; 220(2):492-8. PubMed ID: 19418484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fragile histidine triad expression delays tumor development and induces apoptosis in human pancreatic cancer.
    Dumon KR; Ishii H; Vecchione A; Trapasso F; Baldassarre G; Chakrani F; Druck T; Rosato EF; Williams NN; Baffa R; During MJ; Huebner K; Croce CM
    Cancer Res; 2001 Jun; 61(12):4827-36. PubMed ID: 11406559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.